KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Shareholder's Equity (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -0.44%
Dec 28, 2025 2.86%
Sep 28, 2025 1.02%
Jun 29, 2025 0.47%
Mar 30, 2025 9.26%
Dec 29, 2024 1.90%
Sep 29, 2024 -1.93%
Jun 30, 2024 2.17%
Mar 31, 2024 1.81%
Dec 31, 2023 -3.45%
Oct 1, 2023 -6.78%
Jul 2, 2023 7.82%
Apr 2, 2023 -7.73%
Jan 1, 2023 2.96%
Oct 2, 2022 -2.30%
Jul 3, 2022 2.21%
Apr 3, 2022 0.93%
Jan 2, 2022 5.34%
Oct 3, 2021 0.99%
Jul 4, 2021 5.69%
Apr 4, 2021 4.04%
Jan 3, 2021 -1.85%
Sep 27, 2020 2.37%
Jun 28, 2020 2.75%
Mar 29, 2020 3.07%
Dec 29, 2019 2.17%
Sep 29, 2019 -4.24%
Jun 30, 2019 3.10%
Mar 31, 2019 -1.33%
Dec 30, 2018 -7.54%
Sep 30, 2018 2.76%
Jul 1, 2018 -0.58%
Apr 1, 2018 5.14%
Dec 31, 2017 -18.68%
Oct 1, 2017 2.86%
Jul 2, 2017 2.25%
Apr 2, 2017 -0.11%
Jan 1, 2017 -3.23%
Oct 2, 2016 0.41%
Jul 3, 2016 -0.24%
Apr 3, 2016 2.10%
Jan 3, 2016 -0.56%
Sep 27, 2015 0.59%
Jun 28, 2015 4.79%
Mar 29, 2015 -2.69%
Dec 28, 2014 -8.93%
Sep 28, 2014 -1.87%
Jun 29, 2014 1.91%
Mar 30, 2014 3.42%
Dec 29, 2013 6.09%
Sep 29, 2013 0.20%
Jun 30, 2013 4.20%
Mar 31, 2013 3.13%
Dec 30, 2012 1.67%
Sep 30, 2012 5.51%
Jul 1, 2012 -1.52%
Apr 1, 2012 7.51%
Jan 1, 2012 -7.23%
Oct 2, 2011 -0.97%
Jul 3, 2011 3.79%
Apr 3, 2011 5.80%
Jan 2, 2011 -1.24%
Oct 3, 2010 8.40%
Jul 4, 2010 -0.12%
Apr 4, 2010 4.60%
Jan 3, 2010 0.40%
Sep 27, 2009 8.95%